Patent: 10,273,252
✉ Email this page to a colleague
Summary for Patent: 10,273,252
Title: | Substituted dihydropyrrolopyrazole derivative |
Abstract: | The present invention provides a compound represented by the general formula (Ia) or a pharmacologically acceptable salt thereof. In the general formula (Ia), two R moieties each independently represent a C.sub.1-3 alkyl group or the like; and R.sup.1, R.sup.2 and R.sup.3 each independently represent an optionally substituted linear or branched C.sub.1-4 alkyl group. ##STR00001## |
Inventor(s): | Iwase; Noriaki (Ube, JP), Aga; Yasuhiro (Ube, JP), Ushiyama; Shigeru (Ube, JP), Kono; Shigeyuki (Ube, JP), Sunamoto; Hidetoshi (Ube, JP), Matsushita; Takashi (Ube, JP), Ogi; Sayaka (Ube, JP), Umezaki; Satoshi (Ube, JP), Kojima; Masahiro (Ube, JP), Onuma; Kazuhiro (Ube, JP), Shiraishi; Yusuke (Ube, JP), Okudo; Makoto (Ube, JP), Kimura; Tomio (Tokyo, JP) |
Assignee: | UBE INDUSTRIES, LTD. (Yamaguchi, JP) |
Application Number: | 15/736,677 |
Patent Claims: | see list of patent claims |
Details for Patent 10,273,252
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2036-04-28 |
Bayer Healthcare Pharmaceuticals Inc. | BETASERON | interferon beta-1b | For Injection | 103471 | 07/23/1993 | ⤷ Try a Trial | 2036-04-28 |
Biogen Inc. | AVONEX | interferon beta-1a | For Injection | 103628 | 05/17/1996 | ⤷ Try a Trial | 2036-04-28 |
Biogen Inc. | AVONEX | interferon beta-1a | Injection | 103628 | 05/28/2003 | ⤷ Try a Trial | 2036-04-28 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |